Kimia Kala Razi Company (KIMAZI) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- KIMAZI
- Industry
- Pharmaceuticals
- Market
- Iran Fara Bourse
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 |
|---|---|---|
| Operating revenue | 7,244,686 | 3,924,028 |
| Cost of operating revenue | -3,107,761 | -2,001,748 |
| Gross profit (loss) | 4,136,925 | 1,922,280 |
| Selling, general and administrative expenses | -656,712 | -363,462 |
| Other income | 636 | 507 |
| Other expenses | -585 | -20,022 |
| Operating profit (loss) | 3,480,264 | 1,539,303 |
| Finance costs | -136,180 | -83,931 |
| Other non-operating income and expenses | -83,699 | 6,249 |
| Profit (loss) from continuing operations before tax | 3,260,385 | 1,461,621 |
| Current year tax | -521,570 | -232,200 |
| Net profit (loss) from continuing operations | 2,940,461 | 1,229,421 |
| Net profit (loss) | 2,940,461 | 1,229,421 |
| Basic earnings (loss) per share | 1,832 rials | 2,319 rials |
| Net earnings (loss) per share, rials | 1,833 rials | 2,298 rials |
| Capital | 1,605,000 | 535,000 |
Reporting periods
14 periods are on file for this report, from the period ending 1399/12/30 to the period ending 1405/06/31.